{"Q": 1, "answer": "no", "rationale": "The segment contains 'too early', which modifies 'tell', not a risk adjective.", "method": "llm_batch", "batch_id": "batch_1_12404", "batch_size": 200, "batch_pos": 170, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The language used is neutral and descriptive.", "method": "llm_batch", "batch_id": "batch_2_15268", "batch_size": 200, "batch_pos": 122, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses manufacturing capacity, lacking a moderate verb paired with explicit scale or impact.", "method": "llm_batch", "batch_id": "batch_3_16912", "batch_size": 200, "batch_pos": 66, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_18160", "batch_size": 200, "batch_pos": 50, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports uncertainty about manufacturing scale, which is not calming.", "method": "llm_batch", "batch_id": "batch_5_16816", "batch_size": 200, "batch_pos": 45, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_9820", "batch_size": 200, "batch_pos": 4, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_13704", "batch_size": 200, "batch_pos": 185, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes development capability ('how many doses Moderna will be able to manufacture').", "method": "llm_batch", "batch_id": "batch_8_7020", "batch_size": 200, "batch_pos": 4, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
